83 related articles for article (PubMed ID: 22435140)
41. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner.
Ho-Tin-Noé B; Le Dall J; Gomez D; Louedec L; Vranckx R; El-Bouchtaoui M; Legrès L; Meilhac O; Michel JB
Circ Res; 2011 Oct; 109(9):1003-14. PubMed ID: 21885829
[TBL] [Abstract][Full Text] [Related]
42. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha.
Lin CM; Chiu JH; Wu IH; Wang BW; Pan CM; Chen YH
J Nutr Biochem; 2010 Jul; 21(7):627-33. PubMed ID: 19443196
[TBL] [Abstract][Full Text] [Related]
43. PPARγ-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway.
Wang SH; Guo YJ; Yuan Y; Li L; Li FF; Ye KP; Huang Y
Toxicol Lett; 2011 Oct; 206(3):339-46. PubMed ID: 21835234
[TBL] [Abstract][Full Text] [Related]
44. PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells.
Ho TC; Chen SL; Yang YC; Liao CL; Cheng HC; Tsao YP
Cardiovasc Res; 2007 Nov; 76(2):213-23. PubMed ID: 17651710
[TBL] [Abstract][Full Text] [Related]
45. Expression of adhesion molecules by cultured human glomerular endothelial cells in response to cytokines: comparison to human umbilical vein and dermal microvascular endothelial cells.
Murakami S; Morioka T; Nakagawa Y; Suzuki Y; Arakawa M; Oite T
Microvasc Res; 2001 Nov; 62(3):383-91. PubMed ID: 11678640
[TBL] [Abstract][Full Text] [Related]
46. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
47. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2011 Sep; 43(10):731-4. PubMed ID: 21932180
[TBL] [Abstract][Full Text] [Related]
48. Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding.
Mahali SK; Manna SK
Biochem Pharmacol; 2012 Dec; 84(12):1681-90. PubMed ID: 23058985
[TBL] [Abstract][Full Text] [Related]
49. Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells.
Tezuka M; Koyama N; Morisaki N; Saito Y; Yoshida S; Araki N; Horiuchi S
Biochem Biophys Res Commun; 1993 Jun; 193(2):674-80. PubMed ID: 7685599
[TBL] [Abstract][Full Text] [Related]
50. Bezafibrate restores the inhibition of FSH-induced follicular development and steroidogenesis by tumor necrosis factor-alpha through peroxisome proliferator-activated receptor-gamma pathway in an in vitro mouse preantral follicle culture.
Hara S; Takahashi T; Amita M; Igarashi H; Tsutsumi S; Kurachi H
Biol Reprod; 2011 Nov; 85(5):895-906. PubMed ID: 21734263
[TBL] [Abstract][Full Text] [Related]
51. Trans-10, cis-12 conjugated linoleic acid and the PPAR-γ agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-α production by bovine immune cells.
Perdomo MC; Santos JE; Badinga L
Domest Anim Endocrinol; 2011 Oct; 41(3):118-25. PubMed ID: 21798687
[TBL] [Abstract][Full Text] [Related]
52. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
Chen M; Li H; Wang G; Shen X; Zhao S; Su W
Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
[TBL] [Abstract][Full Text] [Related]
53. PPAR-γ agonist GW1929 but not antagonist GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells.
Wojtowicz AK; Szychowski KA; Kajta M
Neurotox Res; 2014 Apr; 25(3):311-22. PubMed ID: 24132472
[TBL] [Abstract][Full Text] [Related]
54. Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.
El-Bassossy HM; Abo-Warda SM; Fahmy A
Am J Chin Med; 2014; 42(5):1153-67. PubMed ID: 25169908
[TBL] [Abstract][Full Text] [Related]
55. Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic.
Soumya SJ; Binu S; Helen A; Anil Kumar K; Reddanna P; Sudhakaran PR
Inflamm Res; 2012 Jul; 61(7):707-18. PubMed ID: 22450700
[TBL] [Abstract][Full Text] [Related]
56. Advanced glycation end products of bovine serum albumin affect the cell growth of human umbilical vein endothelial cells via modulation of MEG3/miR-93/p21 pathway.
Ju C; Sheng Z; Wang Q; Li Y; Wang X; Li S; Qi Q; Yuan Z
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):41-50. PubMed ID: 30544204
[TBL] [Abstract][Full Text] [Related]
57. Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.
Terrasi M; Bazan V; Caruso S; Insalaco L; Amodeo V; Fanale D; Corsini LR; Contaldo C; Mercanti A; Fiorio E; Lo Re G; Cicero G; Surmacz E; Russo A
J Cell Physiol; 2013 Jun; 228(6):1368-74. PubMed ID: 23254958
[TBL] [Abstract][Full Text] [Related]
58. Effect of sarcosine on endothelial function relevant to angiogenesis.
Sudhakaran PR; Binu S; Soumya SJ
J Cancer Res Ther; 2014; 10(3):603-10. PubMed ID: 25313747
[TBL] [Abstract][Full Text] [Related]
59. Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.
Di Marco GS; Alam A; Dol F; Corvol P; Gasc JM; Larger E
Mol Med; 2008; 14(11-12):705-14. PubMed ID: 18670619
[TBL] [Abstract][Full Text] [Related]
60. The Contribution of EDF1 to PPARγ Transcriptional Activation in VEGF-Treated Human Endothelial Cells.
Cazzaniga A; Locatelli L; Castiglioni S; Maier J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
